Rakesh Raman

Canterbury, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).

Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).

Journal: European urology

Published: March 26, 2024

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 20, 2023

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

Journal: Lancet (London, England)

Published: October 05, 2023

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

Journal: Lancet (London, England)

Published: July 21, 2023

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.

Journal: Cancers

Published: April 03, 2023

Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit.

Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit.

Journal: Diseases (Basel, Switzerland)

Published: March 09, 2022

Effect of the learning curve on survival after laparoscopic liver resection for colorectal metastases.

Effect of the learning curve on survival after laparoscopic liver resection for colorectal metastases.

Journal: BJS open

Published: November 10, 2021

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Journal: Journal of medical genetics

Published: September 08, 2020

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.

Journal: Lancet (London, England)

Published: January 31, 2020

Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.

Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 10, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026